The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
ASPP Proteins Specifically Stimulate the Apoptotic Function of p53
Open accessAbstract
We identified a family of proteins termed ASPP. ASPP1 is a protein homologous to 53BP2, the C-terminal half of ASPP2. ASPP proteins interact with p53 and specifically enhance p53-induced apoptosis but not cell cycle arrest. Inhibition of endogenous ASPP function suppresses the apoptotic function of endogenous p53 in response to apoptotic stimuli. ASPP enhance the DNA binding and transactivation function of p53 on the promoters of proapoptotic genes in vivo. Two tumor-derived p53 mutants with reduced apoptotic function were defective in cooperating with ASPP in apoptosis induction. The expression of ASPP is frequently downregulated in human breast carcinomas expressing wild-type p53 but not mutant p53. Therefore, ASPP regulate the tumor suppression function of p53 in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The miR-21 targets we identified included p53 homologue, p63, p53 activators JMY, TOPORS, TP53BP2, DAXX, and HNRPK, which can stabilize p53 protein levels by interfering with MDM2 and/or act as p53 transcriptional cofactors, assisting p53 in transactivating genes that can induce apoptosis and growth arrest (21)(22)(23)(24)(25)(26).”
From MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells (2008) · cites this paper as [23]
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2
Gorina, S. S., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.1001 · Cited by 575
Two cellular proteins that bind to wild-type but not mutant p53.
Iwabuchi, K., Bartel, P. L., Li, B., Marraccino, R. L., & Fields, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6098 · Cited by 432
In vivo gene expression profile analysis of human breast cancer progression.
Sgroi, D. C., Teng, S., ROBINSON, G. C., LeVangie, R., Hudson, J. R., & Elkahloun, A. G. (1999) · PubMed · Cited by 390
Differential Activation of Target Cellular Promoters by p53 Mutants with Impaired Apoptotic Function
Ludwig, R. L., Bates, S., & Vousden, K. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4952 · Cited by 278
Hsieh, J.-K., Fredersdorf, S., Kouzarides, T., Martin, K., & Lü, X. (1997) · Genes & Development · doi:10.1101/gad.11.14.1840 · Cited by 278
Self-citationA Mutant p53 That Discriminates between p53-Responsive Genes Cannot Induce Apoptosis
Friedlander, P. A., Haupt, Y., Prives, C. L., & Oren, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4961 · Cited by 277
Stimulation of p53-mediated Transcriptional Activation by the p53-binding Proteins, 53BP1 and 53BP2
Iwabuchi, K., Li, B., Massa, H. F., Trask, B. J., Date, T., & Fields, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26061 · Cited by 206
Crook, T., Brooks, L. A., Crossland, S., Osin, P., Barker, K. T., Waller, J., Philp, E., Smith, P. D., Yuluğ, I. G., Peto, J., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202106 · Cited by 179
Self-citation
Cited by
Sorted by citations
Items 601–663 of 663
Identification of novel and direct target genes of p73
Lapi, E. (2008) · Cineca Institutional Research Information System (Tor Vergata University)
INTEGRACIÓN DE LA FUNCIÓN DE VRK2 EN LAS RUTAS DE SEÑALIZACIÓN DE JNK Y P53.
Blanco, S. (2006) · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Montalto, G., Carroccio, A., Soresi, M., Marco, C. D., Averna, M. R., & Notarbartolo, A. (1991) · PubMed
Efferth, T., & Kaina, B. (2009) · Science Publishers eBooks · doi:10.1201/b10200-15
Rigamonti, D. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139382816.002
p53 Tumor Suppressor Opens Gateways for Cancer Therapy
Dai, M., Gallegos, J. R., & Lu, H. (2008) · CRC Press eBooks · doi:10.1201/9780849387999.ch48
Changing the balance in apoptosis: key to enhance cisplatin sensitivity of testicular cancer
Koster, R. (2010) · University of Groningen research database (University of Groningen / Centre for Information Technology)
A. Apoptosis and the Genesis of Tumors
Stewart, B. W. (2003)
Characterisation of the role of ING5
Basavarajaiah, P., & Lüscher, B. (2005) · RWTH Publications (RWTH Aachen)
An investigation of mutant p53 function.
Noll, J. E. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
ASPP-MEDIATED DEPHOSPHORYLATION OF P53 BY PROTEIN PHOSPHATASE 1C
Millott, R. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3qf8jz7f
Hsieh, T., Doonan, B. B., & WU, J. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813008-7.00014-x
De Novo Deletion 17p (del17p) in an Adult T-Cell Prolymphocytic Leukemia as a Rare Presentation
Bashir, Z.-T.-A., Siddiqui, S., Hassan, J., & Shamsi, T. S. (2019) · National Journal of Health Sciences · doi:10.21089/njhs.41.0042
Wang, Y., Wang, J. N., Chen, X. Z., Hu, Q. X., Liu, Q. Q., & Wu, G. (2019) · Bulletin of Entomological Research · doi:10.1017/s0007485319000543
P53 and the Carcinoma of the Breast: A Review
Agrawal, S. N., & Nayak, A. (2020) · Academia Journal of Surgery · doi:10.47008/ajs/2020.3.1.21
Characterization of NEK10 Tyrosine Kinase Activity in the Cellular Response to DNA Damage
Haider, N. (2018) · TSpace (University of Toronto)
Howe, F. S., & Lü, X. (2020) · FEBS Journal · doi:10.1111/febs.15591
INTERACTOME REWIRING THROUGH CANCER-ASSOCIATED MUTATION IN GROWTH FACTOR SIGNALING PATHWAYS
Wong, C.-J. (2017) · TSpace (University of Toronto)
Das, P., & Mattaparthi, V. S. K. (2021) · Current Chemical Biology · doi:10.2174/2212796815666210716151211
Sapienza, C. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1158826.627237
Friedberg, E. C., Walker, G. C., Siede, W., Wood, R. D., Schultz, R. A., & Ellenberger, T. E. (2014) · ASM Press eBooks · doi:10.1128/9781555816704.ch21
Stewart, B. W. (2003) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-08602-5_6
DNA Damage and the Regulation of Cell Fate
Friedberg, E. C., Walker, G. C., Siede, W., Wood, R. D., Schultz, R. A., & Ellenberger, T. E. (2014) · ASM Press eBooks · doi:10.1128/9781555816704.ch23
The C. elegans ASPP homolog APE-1 is a junctional protein phosphatase 1 modulatorPreprint
Beacham, G. M., Wei, D. T., Beyrent, E., Zhang, Y., Zheng, J., Camacho, M. M. K., Florens, L. A., & Hollopeter, G. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.15.480428
Self-association of adenovirus 5 E1B-55 kDa as well as p53 is essential for their mutual interaction
Morawska, M. (2009) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3292
Schwartz, S. M. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1158826.620066
Blagosklonny, M. V., & Gudkov, A. V. (2010) · Oncotarget · doi:10.18632/oncotarget.15138
Hassan, A. A., Abaker, M. E., & Osman, N. A. (2023) · Research Square · doi:10.21203/rs.3.rs-2508543/v1
Data from Role for Krüppel-Like Factor 4 in Determining the Outcome of p53 Response to DNA Damage
Zhou, Q., Hong, Y., Zhan, Q., Shen, Y., & Liu, Z. (2023) · doi:10.1158/0008-5472.c.6499568.v1
Millau, J., Bastien, N., Bouchard, É. F., & Drouin, R. (2023) · doi:10.1158/0008-5472.c.6500258
(2023) · Journal of Current Trends in Computer Science Research · doi:10.33140/jctcsr.02.02.01
The mechanism accounting for DNA damage strength modulation of p53 dynamical properties
Ma, A., & Dai, X. (2023) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720023500117
Smirnov, A., Magri, A., Lotz, R., Han, X., Yin, C., Harris, M., Osterburg, C., Dötsch, V., McKeating, J. A., & Lü, X. (2023) · Journal of General Virology · doi:10.1099/jgv.0.001895
Liu, T., Huang, S., Zhang, Q., Xia, Y., Zhang, M., & Sun, B. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011519
Significant value of p53 accumulated in Invasive Ductal Breast CarcinomaPreprint
Baccouche, S., Rebaï, A., Frikha, M., Daoud, J., JLIDI, R., & Gargouri, A. F. (2024) · Research Square · doi:10.21203/rs.3.rs-4010877/v1
Induction of cell death in U2OS human cancer cells by Ta 3 N 5Preprint
Nozaki, T., Watanabe, K., Watanabe, T., & Nakamura, T. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.29.620774
Burgers, E. J., Heldring, M. M., Wijaya, L. S., Danilyuk, T. Y., Su, J., Molenaar, S. J., Bouwman, P., Dévédec, S. E. L., van de Water, B., & Beltman, J. B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.14.670293
ASPPs multimerize protein phosphatase 1
Wei, D. T., Morrison, K. N., Beacham, G. M., Beyrent, E., Habas, C. A., Zhang, Y., Florens, L., & Hollopeter, G. (2025) · PLOS Genetics · doi:10.1371/journal.pgen.1011731
Wang, J., Tao, J., Xia, C., Tang, M., Stoica, A.-F., Yuan, S., Li, Y., Guo, L., Kong, X., & Wang, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.25.690307
Sumoylation of cyclin and its therapeutic potential for cancer
Ryu, H., & Hochstrasser, M. (2025) · Animal Cells and Systems · doi:10.1080/19768354.2025.2598975 · Cited by 1
Drastichová, Z., Rudajev, V., Pallag, G., & Novotny, J. (2021) · Figshare · doi:10.6084/m9.figshare.13788297
Drastichová, Z., Rudajev, V., Pallag, G., & Novotny, J. (2021) · Figshare · doi:10.6084/m9.figshare.13788318
Drastichová, Z., Rudajev, V., Pallag, G., & Novotny, J. (2021) · Figshare · doi:10.6084/m9.figshare.13788291
Modélisation génétique de l'oncogenèse mésothéliale induite par les fibres minérales
Boulangé-Lecomte, C. (2004) · OpenGrey (Institut de l'Information Scientifique et Technique)
Drastichová, Z., Rudajev, V., Pallag, G., & Novotny, J. (2021) · Figshare · doi:10.6084/m9.figshare.13788321
Drastichová, Z., Rudajev, V., Pallag, G., & Novotny, J. (2021) · Figshare · doi:10.6084/m9.figshare.13788303
NF-κB signaling pathway mediates the anti-tumor effect of Ginsenoside Rg1 in glioblastoma
Li, S., Chang, J., Chi, B., Liu, Y. S., & Xiang, J. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102548
Wang, C., Fan, N., Yun, T., Li, F., 蒙念龙, Wang, Y., An, J., & Lyu, X. (2026) · Diagnostics · doi:10.3390/diagnostics16101418
Physiological responses of broiler embryos to egg storage duration: A transcriptomics study
Pennings, A. M. M. A., Diehl, K., Wijnen, H. J., & van den Brand, H. (2026) · animal · doi:10.1016/j.animal.2026.101943
Early Life Exposure to Air Pollutants and Childhood Asthma
Gorska, M. M. (2026) · Current Allergy and Asthma Reports · doi:10.1007/s11882-026-01293-2
Okuwaki, M. (2026) · The Journal of Biochemistry · doi:10.1093/jb/mvag065
Shi, D. (2010) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/hfsb-j486
The p53 Master Regulator and Rules of Engagement with Target Sequences
Inga, A., Jordan, J. J., Menéndez, D., Sanctis, V. D., & Resnick, M. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00265-5
Metadata
- Authors
- Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., & Lu, X.
- Affiliations
- Ludwig Cancer Research (GB)
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 8
- Issue
- 4
- Pages
- 781-794
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2087732778
- Cited by
- 664
- References
- 22
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 15 · 2023: 20 · 2022: 16 · 2021: 26 · 2020: 13 · 2019: 20 · 2018: 8 · 2017: 27 · 2016: 18 · 2015: 23 · 2014: 37 · 2013: 35 · 2012: 31
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- ASPP1, ASPP2, p53, apoptosis, p53 DNA binding, p53 transactivation, tumor suppression, breast cancer, mutant p53, cell cycle arrest
- MeSH terms
- Breast Neoplasms, Carcinoma, Carrier Proteins, Cell Separation, Female, Flow Cytometry, Humans, Microscopy, Fluorescence, Molecular Sequence Data, Peptide Fragments, Promoter Regions, Genetic, Proto-Oncogene Proteins, Tumor Cells, Cultured, Transcriptional Activation, Tumor Suppressor Protein p53, Cyclins, Apoptosis, Protein Structure, Tertiary, Proto-Oncogene Proteins c-bcl-2, Cyclin-Dependent Kinase Inhibitor p21, Apoptosis Regulatory Proteins, bcl-2-Associated X Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review